CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xiao, G. H.
Right arrow Articles by Yeung, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xiao, G. H.
Right arrow Articles by Yeung, R. S.

Cell Growth & Differentiation, Vol 6, Issue 9 1185-1191, Copyright © 1995 by American Association of Cancer Research


ARTICLES

Identification of tuberous sclerosis 2 messenger RNA splice variants that are conserved and differentially expressed in rat and human tissues

GH Xiao, F Jin and RS Yeung
Division of Medical Science, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.

Tuberous sclerosis 2 (Tsc2) gene is the target of a germline insertion in the Eker rat model of inherited cancer susceptibility. This tumor suppressor gene, when mutated, gives rise to a spectrum of epithelial and nonepithelial neoplasms in the rat, as well as multisystem involvement of hamartomas in the human. In this study, we characterized the rat Tsc2 cDNA and found that it is highly homologous with the human gene, including a conserved rap1GAP catalytic domain. Sequence analysis of independent rat clones from a kidney cDNA library revealed distinct but related variants of the Tsc2 transcripts stemming from alternative splicing involving two noncontiguous exons within the translated region. The first of these, located at amino acids 947 to 990, gives rise to isoforms with or without the 129-bp exon. There exists another variant related to the use of a "cryptic" splice acceptor site in the downstream exon that results in an in-frame 3-bp deletion. A separate 69-bp exon encoding a novel serine-rich amino acid sequence (1272 to 1295) was also alternatively spliced. Together, we have found a minimum of four and potentially eight Tsc2 isoforms that are differentially expressed in a tissue-specific manner. These splice variants are highly conserved in the human gene, suggesting a possible functional role of these Tsc2 isoforms in various cell regulatory and developmental processes.


This article has been cited by other articles:


Home page
Essays Biochem.Home page
P. Razquin Navas and K. Thedieck
Differential control of ageing and lifespan by isoforms and splice variants across the mTOR network
Essays Biochem., July 11, 2017; 61(3): 349 - 368.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
J.-h. Park, S. Arakawa-Takeuchi, S. Jinno, and H. Okayama
Rho-associated Kinase Connects a Cell Cycle-controlling Anchorage Signal to the Mammalian Target of Rapamycin Pathway
J. Biol. Chem., July 1, 2011; 286(26): 23132 - 23141.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
K Mayer, M Goedbloed, K van Zijl, M Nellist, and H-D Rott
Characterisation of a novel TSC2 missense mutation in the GAP related domain associated with minimal clinical manifestations of tuberous sclerosis
J. Med. Genet., May 1, 2004; 41(5): e64 - e64.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Kobayashi, H. Mitani, R.-i. Takahashi, M. Hirabayashi, M. Ueda, H. Tamura, and O. Hino
Transgenic rescue from embryonic lethality and renal carcinogenesis in the Eker rat model by introduction of a wild-type Tsc2 gene
PNAS, April 15, 1997; 94(8): 3990 - 3993.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
G.-H. Xiao, F. Shoarinejad, F. Jin, E. A. Golemis, and R. S. Yeung
The Tuberous Sclerosis 2 Gene Product, Tuberin, Functions as a Rab5 GTPase Activating Protein (GAP) in Modulating Endocytosis
J. Biol. Chem., March 7, 1997; 272(10): 6097 - 6100.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1995 by the American Association of Cancer Research.